在肺腺癌中,PAR2促进恶性瘤
Bao Wang1,2, Ming-Da Wu3, Yue-Jiao Lan3
1Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University Tianjin 300070, China.
American journal of translational research
|January 17, 2025
概括
蛋白酶激活受体-2 (PAR2) 在肺腺癌中被上调,与生存率差和淋巴侵入有关. 抑制PAR2通过促进肺癌细胞的亡来提高化疗的有效性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 蛋白酶激活受体-2 (PAR2) 与瘤恶性瘤有关.
- 它在肺腺癌 (LUAD) 病原发生中的特定作用尚未完全理解.
研究的目的:
- 为了研究PAR2在LUAD组织中的表达.
- 分析PAR2与临床病理特征和生存率之间的相关性.
- 确定PAR2在肺癌细胞中化学抵抗和亡中的作用.
主要方法:
- 对TCGA数据集的分析.
- 西方涂抹和qPCR用于基因和蛋白质表达.
- 免疫组织化学 (IHC) 用于组织分析.
- 在体外研究涉及H1299肺癌细胞中PAR2抑制.
主要成果:
- 与正常肺组织相比,LUAD中PAR2水平显著升高.
- 高PAR2表达与差差分化和淋巴侵入相关.
- 升调的PAR2与患者存活时间的减少有关.
- 通过调节BAX/BCL-2轴和诱导ER压力和亡,PAR2抑制使肺癌细胞对思素敏感.
- PAR2抑制降低了西斯胺诱导的ATF4表达.
结论:
- PAR2上调是LUAD预后不佳的标志物,与不良的临床病理特征有关.
- PAR2在促进亡抵抗和减少LUAD中西斯普拉丁细胞毒性方面发挥着关键作用.
- 向PAR2可能是一个潜在的治疗策略,以提高肺腺癌的化疗疗效率.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


